On Wed. 17th July, 2019, the second session for the Iranian strategic plan was held at Tehran University of Medical Sciences (TUMS).
The major goals and objectives of developing the strategic plan for rare diseases and orphan drugs, main keywords, theories and top proved documents about rare diseases of various countries were discussed at TUMS.
It was decided to ask for the views governmental or private sectors authorities, academic people’s comments and even the rare societies as NGO’s to join interviews for a review . Dr. Mahdi Norouzi, RADOIR Scientific & Research Deputy and head of steering committee of the Iranian strategic plan.